DIASONE SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diasone Sodium, and when can generic versions of Diasone Sodium launch?
Diasone Sodium is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in DIASONE SODIUM is sulfoxone sodium. Additional details are available on the sulfoxone sodium profile page.
Summary for DIASONE SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Patent Applications: | 325 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DIASONE SODIUM at DailyMed |
US Patents and Regulatory Information for DIASONE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | DIASONE SODIUM | sulfoxone sodium | TABLET, DELAYED RELEASE;ORAL | 006044-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |